Meal photos, glucose context, and editable estimates in one reviewable record.
GlucIQ
Type 1 Diabetes

Glucose-Lowering Pills That Work With Insulin

· 3 min read · Reviewed by GlucIQ Clinical Review Workflow
#sglt-inhibitors#dka#cluster:dka

For decades, the only tool for type 1 was insulin. Then came a class of pills — SGLT inhibitors — that work with insulin, and they were genuinely exciting: they lower glucose, help weight, and even improve blood pressure.

But there’s a catch, and it’s a serious one: these pills raise the risk of DKA — sometimes with normal blood sugar. Here’s what you need to know before (or if) your doctor mentions them.

What these pills do

SGLT inhibitors make your kidneys flush excess glucose out through urine. Less glucose in your blood, without needing more insulin. They’re a big deal in type 2 — and research in type 1 found real benefits:

  • Lower glucose and A1c
  • More time in range
  • Weight loss
  • Better blood pressure

For some people with type 1, they’re a genuinely useful add-on. But they change the chemistry of your fuel system in a way that needs respect.

The catch: DKA at “normal” numbers

Here’s the dangerous part: SGLT inhibitors can cause DKA even when your blood sugar isn’t very high. Remember, DKA is about ketones and acidity — and these pills lower glucose by flushing it out, which can push the body into fat-burning mode even at moderate glucose levels.

So the normal DKA warning — “check ketones when your sugar is high” — doesn’t fully apply. You can have normal-looking glucose and still be sliding toward DKA.

The safety rules (if you take them)

The international consensus on these drugs in type 1 is detailed (Danne et al., 2019). The essentials:

  • Never skip insulin while on them. The pills work with insulin; they don’t replace it.
  • Check ketones — not just glucose — when unwell. Blood ketone testing matters more on these drugs.
  • Stop the pill during illness, fasting, surgery, or heavy drinking — the DKA-risk situations. Your care team should give you explicit “stop conditions.”
  • Stay hydrated. The pills flush fluid too.
  • Know the “euglycemic DKA” sign: nausea, vomiting, fatigue with a normal glucose reading — that combination on these pills is an emergency.

Who should NOT be on them

  • People who’ve had DKA recently.
  • People who can’t reliably check ketones or follow stop rules.
  • People who skip insulin doses (the risk compounds).
  • People with certain kidney issues.

The one-minute takeaway

SGLT inhibitors can genuinely help some people with type 1 — lower glucose, more time in range, weight benefits. But they carry a real DKA risk that can hide behind normal blood sugar (Danne et al., 2019). If your doctor suggests them, the question isn’t just “what are the benefits?” — it’s “what are my stop conditions?” Make sure the answer is clear before you start.

References

  • Danne T, et al. International consensus on risk management of diabetic ketoacidosis in patients with type 1 diabetes treated with sodium-glucose cotransporter (SGLT) inhibitors. Diabetes Care. 2019. DOI: 10.2337/dc18-2316